Article info

Download PDFPDF
Concise report
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
  1. Correspondence to Joachim Sieper, Charité, Campus Benjamin Franklin, Medical Clinic I, Rheumatology, Hindenburgdamm 30, 12200 Berlin, Germany; joachim.sieper{at}charite.de
View Full Text

Citation

Song I, Heldmann F, Rudwaleit M, et al
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study

Publication history

  • Accepted February 1, 2011
  • First published March 17, 2011.
Online issue publication 
May 02, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.